Vivani Medical (VANI) Asset Writedowns and Impairment (2016 - 2021)
Vivani Medical (VANI) posted quarterly Asset Writedowns and Impairment of $200000.0 for Q4 2021, little changed year-over-year from $200000.0 in Q4 2020, and down 60.0% quarter-over-quarter from $500000.0 in Q1 2021.
Vivani Medical (VANI) Asset Writedowns and Impairment (2016 - 2021) Analysis & Trends
Vivani Medical's Asset Writedowns and Impairment history runs 6 years deep, the most recent figure standing at $200000.0 for Q4 2021.
- In Q4 2021, Asset Writedowns and Impairment changed 0.0% year-over-year to $200000.0; the TTM figure through Sep 2024 stood at $200000.0 (changed N/A YoY), while the FY2021 annual figure was $700000.0, changed 0.0% from the prior year.
- Asset Writedowns and Impairment for Q4 2021 stood at $200000.0, down from $500000.0 in the prior quarter.
- The five-year high for Asset Writedowns and Impairment was $2.4 million in Q1 2019, with the low at -$92000.0 in Q3 2017.
- The 5-year median for Asset Writedowns and Impairment is $200000.0 (2019), against an average of $405461.5.
- The sharpest annual moves came in 2017 and 2018: Asset Writedowns and Impairment plunged 120.9% in 2017, then soared 907.14% in 2018.
- Vivani Medical's Asset Writedowns and Impairment stood at -$14000.0 in 2017, then jumped by 907.14% to $113000.0 in 2018, then soared by 76.99% to $200000.0 in 2019, then changed by 0.0% to $200000.0 in 2020, then changed by 0.0% to $200000.0 in 2021.
- Business Quant data shows VANI's Asset Writedowns and Impairment at $200000.0 in Q4 2021, $500000.0 in Q1 2021, and $200000.0 in Q4 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Vivani Medical | 120.18 Mn | 100.29 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 200,000.00 |
| Dec 31, 2021 | 200,000.00 |
| Mar 31, 2021 | 500,000.00 |
| Mar 31, 2021 | 500,000.00 |
| Dec 31, 2020 | 200,000.00 |
| Dec 31, 2020 | 200,000.00 |
| Sep 30, 2020 | 700,000.00 |
| Sep 30, 2020 | 700,000.00 |
| Jun 30, 2020 | 700,000.00 |
| Jun 30, 2020 | 700,000.00 |
| Mar 31, 2020 | 400,000.00 |
| Mar 31, 2020 | 400,000.00 |
| Jun 30, 2019 | 200,000.00 |
| Jun 30, 2019 | 200,000.00 |
| Mar 31, 2019 | 2.40 Mn |
| Mar 31, 2019 | 2.40 Mn |
| Dec 31, 2018 | 113,000.00 |
| Dec 31, 2018 | 113,000.00 |
| Dec 31, 2017 | -14,000.00 |
| Dec 31, 2017 | -14,000.00 |